Lung disease with anti-CCP antibodies but not rheumatoid arthritis or connective tissue disease
about
Treatment of rheumatoid arthritis-associated interstitial lung disease: a perspective reviewIdiopathic interstitial pneumonias with connective tissue diseases features: A reviewInterstitial lung disease in undifferentiated forms of connective tissue diseaseThe multifaceted aspects of interstitial lung disease in rheumatoid arthritisPathogenesis and prevention of rheumatic disease: focus on preclinical RA and SLEA roadmap to promote clinical and translational research in rheumatoid arthritis-associated interstitial lung diseaseSafe exposure level for diacetylWhen and where does inflammation begin in rheumatoid arthritis?Role of Autoantibodies in the Diagnosis of Connective-Tissue Disease ILD (CTD-ILD) and Interstitial Pneumonia with Autoimmune Features (IPAF).Cardiovascular disease is increased prior to onset of rheumatoid arthritis but not osteoarthritis: the population-based Nord-Trøndelag health study (HUNT)Sputum autoantibodies in patients with established rheumatoid arthritis and subjects at risk of future clinically apparent disease.Gene, environment, microbiome and mucosal immune tolerance in rheumatoid arthritis.Genetics of Interstitial Lung Disease: Vol de Nuit (Night Flight).The lung may play a role in the pathogenesis of rheumatoid arthritis.Clinical Features of Idiopathic Interstitial Pneumonia with Systemic Sclerosis-Related Autoantibody in Comparison with Interstitial Pneumonia with Systemic SclerosisBronchiectasis is a Model for Chronic Bacterial Infection Inducing Autoimmunity in Rheumatoid Arthritis.The Roles of Cigarette Smoking and the Lung in the Transitions Between Phases of Preclinical Rheumatoid Arthritis.Tumor necrosis factor alpha, citrullination, and peptidylarginine deiminase 4 in lung and joint inflammation.New insights into pediatric idiopathic pulmonary hemosiderosis: the French RespiRare(®) cohort.Pulmonary vasculitis as the first manifestation of rheumatoid arthritis.Can rheumatoid arthritis be prevented?Lungs, joints and immunity against citrullinated proteins in rheumatoid arthritis.Practical Management of Respiratory Comorbidities in Patients with Rheumatoid Arthritis.Mechanisms involved in triggering rheumatoid arthritis.Recent advances in connective tissue disease related interstitial lung disease.Current and emerging treatment options for interstitial lung disease in patients with rheumatic disease.Preclinical Rheumatoid Arthritis: Progress Toward Prevention.Anti-Citrullinated Protein Antibodies Are Associated With Neutrophil Extracellular Traps in the Sputum in Relatives of Rheumatoid Arthritis Patients.The Complex Role of the Lung in the Pathogenesis and Clinical Outcomes of Rheumatoid Arthritis.Potential protein targets of the peptidylarginine deiminase 2 and peptidylarginine deiminase 4 enzymes in rheumatoid synovial tissue and its possible meaning.Anti-Cyclic Citrullinated Peptide Antibody-Positive Meningoencephalitis in the Preclinical Period of Rheumatoid Arthritis.Signs of immune activation and local inflammation are present in the bronchial tissue of patients with untreated early rheumatoid arthritis.Serological and morphological prognostic factors in patients with interstitial pneumonia with autoimmune features.Prevalence and risk factors of asymptomatic bronchiectasis in patients with rheumatoid arthritis at a tertiary care center in Saudi Arabia.Developing better biomarkers for connective tissue disease-associated interstitial lung disease: citrullinated hsp90 autoantibodies in rheumatoid arthritisInterstitial lung disease in suggestive forms of connective tissue diseaseRheumatoid Arthritis-Associated Interstitial Lung Disease and Idiopathic Pulmonary Fibrosis: Shared Mechanistic and Phenotypic Traits Suggest Overlapping Disease Mechanisms.Anti-CCP antibody in a patient with generalized discoid lupus erythematosus, vasculitis and acute interstitial lung disease but not rheumatoid arthritis.Upregulation of citrullination pathway: From Autoimmune to Idiopathic Lung Fibrosis.Interstitial lung disease in systemic autoimmune rheumatic diseases: a comprehensive review.
P2860
Q26775753-59D43D4D-C96C-48F4-A641-6E5BB41E5090Q26799465-134A3843-392F-4F28-8C84-3A38CCBCA6D3Q26860702-9C2F2621-1905-4650-85BE-02DED990AAC7Q26861557-4E060328-C36C-497A-B276-FFAAFC91BF0BQ27003201-5634E73B-BD9D-42C9-8A87-7EF368A62DA9Q27014138-AECD28DD-0A04-4DC8-A4D9-A0FA1B6C9A7CQ28392667-0B866CC8-CBB8-40BD-BABC-F1A7E321F9C0Q33662199-BC5AFB71-83EA-449B-9337-4073B3BD0DC0Q33737250-19414FD2-425E-4F32-B558-85F122294D21Q33766283-E70B1C51-31B7-4AAE-BB13-EE70DC7AA213Q33789860-A494B751-52C1-43F9-80E6-90E85791DFD1Q35533807-C948BF1B-C0AD-4D11-B4F8-E727B5372281Q35649228-47877C8E-E4C3-4257-A035-CB0F4A9FA200Q35747705-892319CB-4FFB-4590-BB85-78D439947AF5Q36114308-E315BBCD-5790-4B3B-BE04-FD448BB28442Q36799841-990187A1-DE58-4980-B5BE-FE4EF8E411EAQ37085750-58E1FA61-1C2C-46F3-B323-8205F5C3FF3AQ37118257-C17F76E6-52A3-4DC5-81CF-46BD09A01CECQ37367611-1D376D12-4141-4551-B8F3-BCA601E2DF65Q37576499-C17625C0-01D0-4C3B-AC2A-D838781398C9Q37589108-E60C2E59-78F4-4319-8A23-BD2D6C5F4F6FQ38235035-DDD81AC4-B441-4568-A1C6-161A2C5E1CA4Q38642378-983EACF0-177C-48FB-AC00-92ED0B722EEDQ38673425-579E40C0-A9A4-4EF4-A3D0-B6409FBD4E07Q38678939-81178C01-D2C6-4A74-98E0-5F094946C396Q38692232-5B257822-E1B0-436D-93DD-F1D00A80E48FQ38712937-97161A40-4E23-4FE0-804E-681958FFC739Q38759315-44CFCBE6-B518-49DD-8317-95FFDBBE7814Q38994767-20688245-4D13-4AFD-9D19-16C7051207D7Q39318037-FD4FD10C-1C31-41EE-9BC4-5F1D585D92A1Q40085886-A4924569-3D41-4D21-BDFC-15B5C67762F2Q40360486-85A0FE02-BC6A-4BE0-8035-692BEF989F63Q41375681-2F320B30-F1B6-40EE-A129-C7B1143B9A59Q42106361-C2DA3AE6-FCD0-49F1-9825-D1D198FB040FQ42592977-97A8DCB3-973D-4237-A26F-A8E8A37CB913Q42715014-814EE692-322A-4C49-AECD-6FEEADE3A23EQ43117087-94A1A10D-2ABA-43BB-A784-826F5D575E53Q46612797-76CC7378-66C1-402E-8D63-DC98784960FFQ47131369-46DA89F1-618A-43E4-98F5-D39D61539EADQ47372819-31C738F4-0465-4F31-8659-2F1532C8B8F6
P2860
Lung disease with anti-CCP antibodies but not rheumatoid arthritis or connective tissue disease
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 April 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Lung disease with anti-CCP ant ...... s or connective tissue disease
@en
Lung disease with anti-CCP ant ...... or connective tissue disease.
@nl
type
label
Lung disease with anti-CCP ant ...... s or connective tissue disease
@en
Lung disease with anti-CCP ant ...... or connective tissue disease.
@nl
prefLabel
Lung disease with anti-CCP ant ...... s or connective tissue disease
@en
Lung disease with anti-CCP ant ...... or connective tissue disease.
@nl
P2093
P2860
P1433
P1476
Lung disease with anti-CCP ant ...... s or connective tissue disease
@en
P2093
Allen D Stevens
Amy L Olson
Aryeh Fischer
Avi M Rabinovitch
David A Burns
David A Lynch
Evans R Fernandez-Perez
Isabel S Pineiro
Jeffrey J Swigris
Joshua J Solomon
P2860
P304
P356
10.1016/J.RMED.2012.03.006
P577
2012-04-12T00:00:00Z